2025/01 - 2024 Highlights [Journal Club]-January JCMR Journal Club Webinar Part 2

Video Transcription

Video Summary

The discussion focused on recent and upcoming advances in cardiac MRI. Highlights included emerging metabolic imaging with hyperpolarized compounds, which may soon become more clinically feasible thanks to automated processing and standardized commercial systems. Another promising technique was refined fat imaging, where Dixon-based methods are being extended to distinguish fatty acid types linked to inflammation.<br /><br />The panel also emphasized AI as a major trend: improving image acquisition and reconstruction, reducing contrast needs, automating post-processing, and enabling automatic disease classification. A related theme was making MRI more efficient by acquiring less data but extracting more clinically meaningful information.<br /><br />Low-field MRI was viewed positively as a potentially cheaper, more scalable option with fewer safety issues and better access for patients with implants or obesity, though some noted that CT is still often preferred clinically for those groups.<br /><br />Looking ahead to 2025, the speakers highlighted studies such as EVOLVE, CMR-ICD, CPF characterization studies, and the MyoFlame trial on post-COVID inflammatory heart disease. They stressed the need for randomized trials showing that CMR changes management and outcomes.

Keywords

cardiac MRI

hyperpolarized compounds

fat imaging

Dixon methods

artificial intelligence

low-field MRI

randomized trials